Not applicableStudy completedNCT04821336What this trial is testingCholesterol Metabolites Analysis in Human Thyroid and Iodine ResistanceWho this might be right forThyroid Cancer Institut Claudius Regaud 30
Testing effectiveness (Phase 2)Looking for participantsNCT07092514What this trial is testingLenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)Who this might be right forThyroid CancerCancer of the Thyroid Washington University School of Medicine 34
Very early researchLooking for participantsNCT06632860What this trial is testingA Dual-targeting Tracer TATE-RGD for the Diagnosis of SSTR- and RGD- Positive TumorsWho this might be right forIodine-resistant Thyroid CancerMeningiomaNETs Peking Union Medical College Hospital 40
Testing effectiveness (Phase 2)Study completedNCT05745363What this trial is testingClinical Study of AL2846 Capsule in the Treatment of Differentiated Thyroid CancerWho this might be right forDifferentiated Thyroid Cancer Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 33
Testing effectiveness (Phase 2)Study completedNCT01286753What this trial is testingVemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 MutationWho this might be right forNeoplasms Hoffmann-La Roche 51
Testing effectiveness (Phase 2)Study completedNCT01013597What this trial is testingTrial of LBH589 in Metastatic Thyroid CancerWho this might be right forThyroid Carcinoma University of Wisconsin, Madison 13